/ Media

2013 ASCO Annual Meeting

May 15th, 2013

Genentech to report new advances at the American Society of Clinical Oncology Annual Meeting

Genentech will present important new data from studies of several cancer medicines at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) from May 31-June 4, 2013, in Chicago.

This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.


Related news releases

Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

Data on investigational Genentech medicine shows significant PFS improvement in people with CLL

Update on Study Results of Medicine in People with Newly Diagnosed Glioblastoma

Genentech's Medicine Improved Survival in Women with Advanced Cervical Cancer

Fact Sheets


Understanding CRC

Colorectal cancer is the third most commonly diagnosed cancer in both men and women in the United States.

Our Oncology Pipeline

We're currently conducting 600 clinical trials in 40 investigational medicines across 25 types of cancer.

About the Lung Cancer Project


Data from The Lung Cancer Project, a study exploring if people, including doctors, have inherent biases against lung cancer, is being presented at this year’s meeting.
Learn more

ASCO Digital Newsroom

Visit our ASCO newsroom to read more about this year's key topics at ASCO.


By The Numbers

275
Abstracts at ASCO
96
Oral Presentations at the meeting
10
Pipeline Medicines with Data